TuHURA BIOSCIENCES, INC./NV Increase (Decrease) in Prepaid Expense and Other Assets
TuHURA BIOSCIENCES, INC./NV (HURA) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$156.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2024-11-14
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense and other assets for the quarter ending 2024-09-30 was -$156.00K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense and other assets for the quarter ending 2024-06-30 was $206.00K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense and other assets for the quarter ending 2024-03-31 was -$103.00K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense and other assets for the quarter ending 2023-12-31 was -$256.00K, a 3300.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$246.00K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$371.00K, a 151.39% decline from fiscal 2022.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense and other assets for fiscal 2022 was $722.00K, a 89.50% increase from fiscal 2021.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expense and other assets for fiscal 2021 was $381.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 14 month | Increase (Decrease) in Prepaid Expense and Other Assets 36 month | Increase (Decrease) in Prepaid Expense and Other Assets 42 month | Increase (Decrease) in Prepaid Expense and Other Assets 45 month | Increase (Decrease) in Prepaid Expense and Other Assets 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -$156.00K 10-Q · filed 2024-11-14 | $50.00K derived: sum of 2 quarters · filed 2024-11-14 | -$53.00K derived: sum of 3 quarters · filed 2024-11-14 | -$309.00K derived: sum of 4 quarters · filed 2024-11-14 | |||||||
| 2024-06-30 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | $103.00K derived: sum of 2 quarters · filed 2024-10-07 | -$153.00K derived: sum of 3 quarters · filed 2024-10-07 | -$246.00K 10-K · filed 2024-10-07 | |||||||
| 2024-03-31 | -$103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | -$359.00K derived: sum of 2 quarters · filed 2024-05-14 | -$452.00K 10-Q · filed 2024-05-14 | -$613.00K derived: sum of 4 quarters · filed 2024-11-14 | |||||||
| 2023-12-31 | -$256.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$349.00K 10-Q · filed 2024-02-14 | -$510.00K derived: sum of 3 quarters · filed 2024-11-14 | -$768.00K derived: sum of 4 quarters · filed 2024-11-14 | |||||||
| 2023-09-30 | -$93.00K 10-Q · filed 2024-11-14 | -$254.00K derived: sum of 2 quarters · filed 2024-11-14 | -$512.00K derived: sum of 3 quarters · filed 2024-11-14 | -$504.00K derived: sum of 4 quarters · filed 2024-11-14 | |||||||
| 2023-06-30 | -$161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | -$419.00K derived: sum of 2 quarters · filed 2024-10-07 | -$411.00K derived: sum of 3 quarters · filed 2024-10-07 | -$371.00K 10-K · filed 2024-10-07 | |||||||
| 2023-03-31 | -$258.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | -$250.00K derived: sum of 2 quarters · filed 2024-05-14 | -$210.00K 10-Q · filed 2024-05-14 | -$486.00K derived: sum of 4 quarters · filed 2024-05-14 | |||||||
| 2022-12-31 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $48.00K 10-Q · filed 2024-02-14 | -$228.00K derived: sum of 3 quarters · filed 2024-02-14 | $92.00K derived: sum of 4 quarters · filed 2024-02-14 | |||||||
| 2022-09-30 | $40.00K 10-Q · filed 2023-11-13 | -$236.00K derived: sum of 2 quarters · filed 2023-11-13 | $84.00K derived: sum of 3 quarters · filed 2023-11-13 | $749.00K derived: sum of 4 quarters · filed 2023-11-13 | |||||||
| 2022-06-30 | -$276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-18 | $44.00K derived: sum of 2 quarters · filed 2023-09-18 | $709.00K derived: sum of 3 quarters · filed 2023-09-18 | $722.00K 10-K · filed 2023-09-18 | |||||||
| 2022-03-31 | $320.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $985.00K derived: sum of 2 quarters · filed 2023-05-11 | $998.00K 10-Q · filed 2023-05-11 | -$1.22M derived: sum of 4 quarters · filed 2023-05-11 | |||||||
| 2021-12-31 | $665.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | $678.00K 10-Q · filed 2023-02-14 | -$1.53M derived: sum of 3 quarters · filed 2023-02-14 | -$1.73M derived: sum of 4 quarters · filed 2023-02-14 | |||||||
| 2021-09-30 | $13.00K 10-Q · filed 2022-11-09 | -$2.20M derived: sum of 2 quarters · filed 2022-11-09 | -$2.39M derived: sum of 3 quarters · filed 2022-11-09 | $418.00K derived: sum of 4 quarters · filed 2022-11-09 | |||||||
| 2021-06-30 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$2.40M derived: sum of 2 quarters · filed 2022-09-27 | $405.00K derived: sum of 3 quarters · filed 2022-09-27 | $381.00K 10-K · filed 2022-09-27 | |||||||
| 2021-03-31 | -$190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $2.62M derived: sum of 2 quarters · filed 2022-05-13 | $2.59M 10-Q · filed 2022-05-13 | ||||||||
| 2020-12-31 | $2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | $2.78M 10-Q · filed 2022-02-11 | |||||||||
| 2020-09-30 | -$24.00K 10-Q · filed 2021-11-15 | ||||||||||
| 2014-09-30 | -$72.38K 10-Q · filed 2014-11-07 | -$107.34K derived: sum of 2 quarters · filed 2014-11-07 | -$8.64K derived: sum of 3 quarters · filed 2014-11-07 | $299.66K derived: sum of 4 quarters · filed 2014-11-07 | |||||||
| 2014-06-30 | -$34.96K derived: 10-K 6 month − 10-Q 3 month · filed 2014-08-28 | $63.74K 10-K · filed 2014-08-28 | $372.04K derived: sum of 3 quarters · filed 2014-08-28 | $345.74K derived: sum of 4 quarters · filed 2014-11-07 | |||||||
| 2014-03-31 | $98.70K 10-Q · filed 2014-05-15 | $407.00K derived: sum of 2 quarters · filed 2014-08-28 | $380.70K derived: sum of 3 quarters · filed 2014-11-07 | $518.43K derived: sum of 4 quarters · filed 2014-11-07 | $269.58K 10-Q · filed 2014-05-15 | ||||||
| 2013-12-31 | $308.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-28 | $282.00K derived: sum of 2 quarters · filed 2014-11-07 | $419.73K derived: sum of 3 quarters · filed 2014-11-07 | $142.10K 10-K · filed 2014-08-28 | $170.88K 10-K · filed 2014-03-10 | ||||||
| 2013-09-30 | -$26.30K 10-Q · filed 2014-11-07 | $111.44K derived: sum of 2 quarters · filed 2014-11-07 | -$166.19K 10-Q · filed 2013-11-08 | $211.92K derived: sum of 4 quarters · filed 2014-11-07 | -$225.97K 10-Q · filed 2013-11-08 | ||||||
| 2013-06-30 | $137.73K derived: 10-K 6 month − 10-Q 3 month · filed 2014-08-28 | $192.48K 10-K · filed 2014-08-28 | -$192.48K 10-Q · filed 2013-08-12 | $238.21K derived: sum of 3 quarters · filed 2014-08-28 | $235.50K derived: sum of 4 quarters · filed 2014-08-28 | -$221.26K 10-Q · filed 2013-08-12 | |||||
| 2013-03-31 | $54.75K 10-Q · filed 2014-05-15 | -$54.75K 10-Q · filed 2013-05-15 | $100.48K derived: sum of 2 quarters · filed 2014-08-28 | $97.76K derived: sum of 3 quarters · filed 2014-08-28 | $113.23K derived: sum of 4 quarters · filed 2014-08-28 | -$83.53K 10-Q · filed 2013-05-15 | |||||
| 2012-12-31 | $45.73K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-28 | $43.01K derived: sum of 2 quarters · filed 2014-08-28 | $58.47K derived: sum of 3 quarters · filed 2014-08-28 | $14.58K 10-K · filed 2014-08-28 | |||||||
| 2012-09-30 | -$2.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $12.74K derived: sum of 2 quarters · filed 2013-11-08 | -$31.15K 10-Q · filed 2013-11-08 | ||||||||
| 2012-06-30 | $15.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$28.43K 10-Q · filed 2013-08-12 | |||||||||
| 2012-03-31 | -$43.89K 10-Q · filed 2013-05-15 | ||||||||||
| 2011-12-31 | $4.10K 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |